| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |